Placebo for glomerulosclerosis, focal segmental

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Oct 2025: Trial registered, NCT07220083
  2. 16 Feb 2026: Trial started, NCT07220083

The trials

NCT07220083: A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

State
Under way
Phase
Phase 3
People
286 planned
Started
16 Feb 2026
Primary completion
27 Dec 2028
Arms
Placebo treatment
Results
None posted
  1. 23 Oct 2025: Trial registered
  2. 16 Feb 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.